Kenya Showcases Breakthroughs in TB Diagnosis and Treatment at TICAD9 Side Event
Yokohama, Japan, Kenya has made remarkable progress in the fight against Tuberculosis, with TB incidence declining by 41% against a 2025 target of 50%, and TB-related deaths reducing by 66% against a target of 75%. In 2024 alone, 96,865 TB cases were notified out of an estimated 124,000, raising treatment coverage to 77%, up from 69% in 2023.
To build on this progress, Kenya is embracing innovation to transform TB prevention, diagnosis, and treatment. The country has deployed AI-assisted X-rays and multimodal AI solutions for faster and more accurate diagnosis, scaled up the Tibu Lite digital health app for real-time patient tracking and community-level screening, and adopted shorter, next-generation therapies for both treatment and prevention.
As Kenya integrates TB services into primary health care and Social Health Insurance, the call is clear: co-investment in smart, scalable innovations is urgently needed to end TB in our lifetime.
Principal Secretary, State Department for Public Health and Professional Standards, Mary Muthoni, attended the side event on harnessing innovation to end TB on the sidelines of TICAD9, where she spotlighted Kenya’s progress and called on partners to join hands in accelerating the fight against TB through technology, investment, and equity-driven approaches.